Related by context. Frequent words. (Click for all words.) 70 Marketplace Rule 68 Nasdaq Listing Rule 68 regain compliance 67 Marketplace Rules 67 NASDAQ Listing Rule 66 Continued Listing 64 NASDAQ Listing 64 Nasdaq Marketplace Rule 63 NASDAQ SmallCap 63 Nasdaq SmallCap Market 62 NASDAQ Listing Qualifications 61 Staff Determination Letter 61 Staff Deficiency Letter 60 delisting determination 60 Listing Qualifications Panel 60 Nasdaq Listing Qualifications 59 Staff Determination 58 NASDAQ Marketplace Rule 58 delisting proceedings 58 Statutory Basis 58 Listing Rule 57 Late Filing 57 Listing Requirements 56 Stock Repurchase Plan 56 Option Grants 55 NYSE Amex Equities 54 NASDAQ 54 Symbol Change 54 NASDAQ Stock 54 Listing Qualifications 54 Shareholder Approval 53 RPRX 53 Non Compliance 53 EVCI 53 Shelf Registration Statement 53 symbol GGP 53 Requisite Consents 53 Make Normal Course 53 NYSE Amex 52 Share Repurchase Plan 52 NASDAQ Global 52 Salix trades 52 Nasdaq 52 NASDAQ Small Cap 52 Proposed Qualifying Transaction 52 Repurchase Program 52 Common Stock 51 ticker symbol SLXP 51 Share Repurchases 51 Annual Meeting Date 51 Dividend Payment 51 stockholders equity 51 Commence Trading 51 Million Share Repurchase 51 Extends Tender Offer 51 EpiCept Corporation 50 Indenture governing 50 Avanex Corporation 50 Proposed Rule Change 50 Indentures 50 Convertible Senior Subordinated 50 Reverse Stock 50 Nasdaq OMX Stockholm 50 netGuru 50 PMFG 50 Default Status Report 50 symbol COOL 50 Private Placement Offering 50 NYSE Alternext 50 stockholder approvals 49 Stock Repurchase Program 49 GEM Listing Rules 49 Concurrent Financing 49 .# Per Share 49 Share Repurchase Program 49 Second Amended 49 Zero Coupon Notes 49 IS NOT FOR DISTRIBUTION 49 Share Repurchase 49 Secondary Offering 49 Private Placement Non Brokered 49 XNPT 49 Beneficial Interest 49 Announces Share Repurchase 48 AKRX 48 Conversion Date 48 Special Cash Dividend 48 SOMX 48 vesting provisions 48 validly revoked 48 % Convertible Subordinated 48 Warrantholders 48 Complete Response letter 48 Previously Announced 48 Print Issue 48 Principal Amount 48 Nasdaq Stock 48 Subsequent Offering 48 Final Approval 48 ADVENTRX Pharmaceuticals Inc. 47 Form 8K